Page last updated: 2024-10-28

gyki 52466 and Depression, Endogenous

gyki 52466 has been researched along with Depression, Endogenous in 2 studies

GYKI 52466: an AMPA (non-NMDA) receptor antagonist; structure given in first source

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, B1
Hou, Y1
Zhu, M1
Bao, H1
Nie, J1
Zhang, GY1
Shan, L1
Yao, Y1
Du, K1
Yang, H1
Li, M1
Zheng, B1
Xu, X1
Xiao, C1
Du, J1
Farley, S1
Apazoglou, K1
Witkin, JM1
Giros, B1
Tzavara, ET1

Other Studies

2 other studies available for gyki 52466 and Depression, Endogenous

ArticleYear
3'-Deoxyadenosine (Cordycepin) Produces a Rapid and Robust Antidepressant Effect via Enhancing Prefrontal AMPA Receptor Signaling Pathway.
    The international journal of neuropsychopharmacology, 2016, Volume: 19, Issue:4

    Topics: Animals; Antidepressive Agents; Benzodiazepines; Deoxyadenosines; Depressive Disorder; Disease Model

2016
Antidepressant-like effects of an AMPA receptor potentiator under a chronic mild stress paradigm.
    The international journal of neuropsychopharmacology, 2010, Volume: 13, Issue:9

    Topics: Animals; Antidepressive Agents; Behavior, Animal; Benzodiazepines; Chronic Disease; Depression; Depr

2010